Skip to main content
Ryvu Therapeutics S.A. (WSE:RVU)
Poland flag Poland · Delayed Price · Currency is PLN
25.50
-0.05 (-0.20%)
At close: Mar 9, 2026

Ryvu Therapeutics Ratios and Metrics

Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year
 CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
 Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
5908901,3291,1391,120903
Upgrade
Market Cap Growth
-7.61%-33.04%16.75%1.70%23.98%25.66%
Upgrade
Enterprise Value
5487241,0821,0981,035747
Upgrade
Last Close Price
25.5038.5057.5049.2561.0049.20
Upgrade
PS Ratio
6.528.7319.7616.6431.6224.44
Upgrade
PB Ratio
8.286.195.123.326.944.04
Upgrade
P/TBV Ratio
9.186.565.253.367.084.08
Upgrade
P/FCF Ratio
---75.58--
Upgrade
P/OCF Ratio
---53.41--
Upgrade
PEG Ratio
-3.413.413.413.413.41
Upgrade
EV/Sales Ratio
6.067.1016.0816.0529.2120.22
Upgrade
EV/FCF Ratio
-4.71--72.90--
Upgrade
Debt / Equity Ratio
1.340.770.040.040.080.03
Upgrade
Debt / FCF Ratio
---0.84--
Upgrade
Net Debt / Equity Ratio
-0.58-0.80-0.86-0.26-0.46-0.69
Upgrade
Net Debt / EBITDA Ratio
0.371.032.561.541.115.88
Upgrade
Net Debt / FCF Ratio
0.360.852.40-5.961.063.43
Upgrade
Asset Turnover
0.280.260.150.190.140.15
Upgrade
Inventory Turnover
10.0211.779.069.377.565.37
Upgrade
Quick Ratio
2.162.343.828.092.765.00
Upgrade
Current Ratio
2.272.523.998.212.885.10
Upgrade
Return on Equity (ROE)
-95.34%-55.24%-30.55%-33.20%-41.08%-18.41%
Upgrade
Return on Assets (ROA)
-23.11%-19.50%-13.86%-12.34%-18.80%-9.31%
Upgrade
Return on Invested Capital (ROIC)
-45.46%-380.19%-67.32%-40.89%-101.00%-55.95%
Upgrade
Return on Capital Employed (ROCE)
-66.30%-45.00%-29.20%-16.20%-41.00%-13.60%
Upgrade
Earnings Yield
-20.13%-12.52%-6.93%-7.36%-7.06%-3.51%
Upgrade
FCF Yield
-19.74%-15.21%-7.00%1.32%-6.33%-4.96%
Upgrade
Buyback Yield / Dilution
0.00%-0.97%-24.75%--9.48%-4.98%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.